Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Statistical | 1 | 2010 | 122 | 0.340 |
Why?
|
| Pituitary Apoplexy | 1 | 2005 | 1 | 0.250 |
Why?
|
| Pituitary Neoplasms | 1 | 2005 | 16 | 0.250 |
Why?
|
| Adenoma | 1 | 2005 | 41 | 0.240 |
Why?
|
| Neovascularization, Pathologic | 2 | 2015 | 33 | 0.200 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2016 | 7 | 0.130 |
Why?
|
| Cryosurgery | 2 | 2013 | 20 | 0.130 |
Why?
|
| Monitoring, Intraoperative | 1 | 2016 | 34 | 0.130 |
Why?
|
| Pancreatic Neoplasms | 2 | 2015 | 64 | 0.130 |
Why?
|
| Scoliosis | 1 | 2016 | 32 | 0.130 |
Why?
|
| Phagocytosis | 1 | 2015 | 41 | 0.120 |
Why?
|
| Blood Platelets | 1 | 2015 | 38 | 0.120 |
Why?
|
| Endothelial Cells | 1 | 2015 | 51 | 0.120 |
Why?
|
| Dietary Proteins | 1 | 2014 | 22 | 0.110 |
Why?
|
| Muscles | 1 | 2014 | 55 | 0.110 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2013 | 4 | 0.110 |
Why?
|
| Combined Modality Therapy | 3 | 2013 | 277 | 0.110 |
Why?
|
| Dendritic Cells | 1 | 2013 | 26 | 0.110 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2013 | 18 | 0.110 |
Why?
|
| Iodine Radioisotopes | 1 | 2012 | 8 | 0.110 |
Why?
|
| Signal Transduction | 1 | 2015 | 389 | 0.100 |
Why?
|
| Brachytherapy | 1 | 2012 | 44 | 0.100 |
Why?
|
| Retinal Ganglion Cells | 1 | 2012 | 2 | 0.100 |
Why?
|
| Glaucoma | 1 | 2012 | 3 | 0.100 |
Why?
|
| Optic Disk | 1 | 2012 | 3 | 0.100 |
Why?
|
| Optic Nerve Diseases | 1 | 2012 | 5 | 0.100 |
Why?
|
| Tomography, Optical Coherence | 1 | 2012 | 15 | 0.100 |
Why?
|
| Nerve Fibers | 1 | 2012 | 12 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 91 | 0.100 |
Why?
|
| Humans | 13 | 2016 | 26017 | 0.100 |
Why?
|
| Tyrosine-tRNA Ligase | 1 | 2011 | 2 | 0.100 |
Why?
|
| Furans | 1 | 2011 | 4 | 0.100 |
Why?
|
| Gram-Positive Bacteria | 1 | 2011 | 12 | 0.100 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2010 | 1 | 0.090 |
Why?
|
| Scleroderma, Systemic | 1 | 2010 | 8 | 0.090 |
Why?
|
| Female | 9 | 2016 | 14395 | 0.080 |
Why?
|
| Algorithms | 1 | 2012 | 358 | 0.080 |
Why?
|
| Adult | 6 | 2016 | 7362 | 0.080 |
Why?
|
| Male | 9 | 2016 | 14005 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2010 | 119 | 0.080 |
Why?
|
| Aged | 7 | 2014 | 8703 | 0.080 |
Why?
|
| Double-Blind Method | 1 | 2010 | 399 | 0.080 |
Why?
|
| Cerebral Arteries | 1 | 2009 | 24 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2009 | 3 | 0.080 |
Why?
|
| ras Proteins | 1 | 2009 | 8 | 0.080 |
Why?
|
| Spinal Fusion | 1 | 2016 | 473 | 0.080 |
Why?
|
| Retrospective Studies | 4 | 2016 | 3294 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2009 | 29 | 0.080 |
Why?
|
| ErbB Receptors | 1 | 2009 | 51 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 338 | 0.080 |
Why?
|
| Middle Aged | 6 | 2014 | 8505 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2009 | 80 | 0.070 |
Why?
|
| Mutation | 1 | 2009 | 311 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 216 | 0.070 |
Why?
|
| Adolescent | 2 | 2016 | 2064 | 0.060 |
Why?
|
| Hypophysectomy | 1 | 2005 | 3 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2013 | 3292 | 0.060 |
Why?
|
| Hormone Replacement Therapy | 1 | 2005 | 18 | 0.060 |
Why?
|
| Substantia Nigra | 1 | 2006 | 113 | 0.060 |
Why?
|
| Neurofibrillary Tangles | 1 | 2006 | 191 | 0.060 |
Why?
|
| Coculture Techniques | 2 | 2015 | 27 | 0.060 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2006 | 139 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2009 | 505 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 485 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 335 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 1140 | 0.040 |
Why?
|
| Aged, 80 and over | 4 | 2012 | 4658 | 0.040 |
Why?
|
| Brain | 1 | 2009 | 1641 | 0.040 |
Why?
|
| Disease Progression | 2 | 2012 | 685 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2010 | 160 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2009 | 2063 | 0.040 |
Why?
|
| Aging | 1 | 2006 | 1535 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2016 | 82 | 0.030 |
Why?
|
| Umbilical Veins | 1 | 2015 | 2 | 0.030 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2015 | 9 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2015 | 25 | 0.030 |
Why?
|
| Cell Communication | 1 | 2015 | 23 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 55 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 111 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 133 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 44 | 0.030 |
Why?
|
| Malaysia | 1 | 2014 | 1 | 0.030 |
Why?
|
| India | 1 | 2014 | 23 | 0.030 |
Why?
|
| Nutrition Assessment | 1 | 2014 | 34 | 0.030 |
Why?
|
| Anthropometry | 1 | 2014 | 35 | 0.030 |
Why?
|
| Apoptosis | 1 | 2015 | 193 | 0.030 |
Why?
|
| China | 1 | 2014 | 50 | 0.030 |
Why?
|
| Arm | 1 | 2014 | 80 | 0.030 |
Why?
|
| Body Weight | 1 | 2014 | 121 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2013 | 48 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 161 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 93 | 0.030 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2014 | 87 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2012 | 55 | 0.020 |
Why?
|
| Child | 1 | 2016 | 1228 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1340 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2013 | 475 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 132 | 0.020 |
Why?
|
| Cytokines | 1 | 2013 | 226 | 0.020 |
Why?
|
| Palliative Care | 1 | 2012 | 104 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2011 | 34 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2014 | 412 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2012 | 298 | 0.020 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2011 | 51 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2011 | 72 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2011 | 63 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 114 | 0.020 |
Why?
|
| Paired Box Transcription Factors | 1 | 2010 | 1 | 0.020 |
Why?
|
| Cyclin A1 | 1 | 2010 | 1 | 0.020 |
Why?
|
| Death-Associated Protein Kinases | 1 | 2010 | 3 | 0.020 |
Why?
|
| Sulfotransferases | 1 | 2010 | 5 | 0.020 |
Why?
|
| Mice | 1 | 2015 | 1280 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 9 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2010 | 13 | 0.020 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2010 | 34 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 1852 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2010 | 47 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2011 | 151 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 362 | 0.020 |
Why?
|
| Gliosis | 1 | 2009 | 6 | 0.020 |
Why?
|
| Arterioles | 1 | 2009 | 9 | 0.020 |
Why?
|
| Encephalitis | 1 | 2009 | 10 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 1365 | 0.020 |
Why?
|
| Microcirculation | 1 | 2009 | 27 | 0.020 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2009 | 15 | 0.020 |
Why?
|
| Cell Count | 1 | 2009 | 75 | 0.020 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2009 | 3 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2009 | 16 | 0.020 |
Why?
|
| Carcinoma, Large Cell | 1 | 2009 | 12 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2009 | 18 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2009 | 37 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 16 | 0.020 |
Why?
|
| Base Sequence | 1 | 2009 | 89 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 104 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 162 | 0.020 |
Why?
|
| Biopsy | 1 | 2009 | 199 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2009 | 202 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2009 | 168 | 0.020 |
Why?
|
| Microglia | 1 | 2009 | 135 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2009 | 123 | 0.020 |
Why?
|
| Survival Rate | 1 | 2009 | 321 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 313 | 0.020 |
Why?
|
| Animals | 1 | 2015 | 3389 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2009 | 318 | 0.020 |
Why?
|
| Prognosis | 1 | 2009 | 750 | 0.020 |
Why?
|
| Biomarkers | 1 | 2009 | 549 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 117 | 0.020 |
Why?
|
| Risk Factors | 1 | 2010 | 2242 | 0.010 |
Why?
|
| Dementia | 1 | 2006 | 527 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 2006 | 826 | 0.010 |
Why?
|